NENCINI, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 2.749
EU - Europa 2.072
AS - Asia 1.440
SA - Sud America 151
Continente sconosciuto - Info sul continente non disponibili 38
AF - Africa 36
OC - Oceania 22
Totale 6.508
Nazione #
US - Stati Uniti d'America 2.694
RU - Federazione Russa 615
IT - Italia 473
SG - Singapore 447
PL - Polonia 443
CN - Cina 366
HK - Hong Kong 165
VN - Vietnam 132
BR - Brasile 121
IE - Irlanda 108
SE - Svezia 103
KR - Corea 96
FI - Finlandia 68
DE - Germania 64
FR - Francia 60
GB - Regno Unito 56
IN - India 56
BD - Bangladesh 50
JO - Giordania 38
CA - Canada 36
AU - Australia 22
JP - Giappone 20
ID - Indonesia 17
NL - Olanda 17
TR - Turchia 16
AR - Argentina 14
BE - Belgio 13
ES - Italia 9
UA - Ucraina 9
CH - Svizzera 8
NG - Nigeria 8
CI - Costa d'Avorio 7
MX - Messico 7
MA - Marocco 6
CO - Colombia 5
CZ - Repubblica Ceca 5
GR - Grecia 5
IQ - Iraq 5
PK - Pakistan 5
ZA - Sudafrica 5
EC - Ecuador 4
LT - Lituania 4
SA - Arabia Saudita 4
AT - Austria 3
KZ - Kazakistan 3
LV - Lettonia 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BJ - Benin 2
CL - Cile 2
CR - Costa Rica 2
DZ - Algeria 2
EE - Estonia 2
GE - Georgia 2
JM - Giamaica 2
MQ - Martinica 2
NP - Nepal 2
PH - Filippine 2
TN - Tunisia 2
UY - Uruguay 2
AM - Armenia 1
BH - Bahrain 1
BY - Bielorussia 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
KE - Kenya 1
MM - Myanmar 1
MY - Malesia 1
NI - Nicaragua 1
OM - Oman 1
PE - Perù 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
SC - Seychelles 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TM - Turkmenistan 1
TW - Taiwan 1
VE - Venezuela 1
Totale 6.470
Città #
Santa Clara 457
Warsaw 442
Ashburn 427
Singapore 314
Fairfield 175
Hong Kong 139
Chandler 136
San Jose 135
Dublin 109
Milan 99
Seoul 96
Beijing 95
Cambridge 84
Woodbridge 84
Ann Arbor 73
Houston 72
Seattle 70
Dallas 64
Wilmington 64
Hefei 57
Buffalo 48
Florence 48
The Dalles 45
Ho Chi Minh City 42
New York 41
Los Angeles 40
Munich 39
Lawrence 37
Altamura 35
Lauterbourg 34
Rome 33
Council Bluffs 32
Princeton 29
Hanoi 27
Moscow 25
Mumbai 23
Shanghai 23
Helsinki 21
Tokyo 20
Jacksonville 19
Medford 19
Melbourne 19
Boardman 18
Kent 18
Paris 15
Turku 15
Boston 14
Figino 13
London 13
Brussels 12
Jakarta 12
Lappeenranta 12
Frankfurt am Main 11
Palermo 11
São Paulo 10
Toronto 10
Chicago 9
Izmir 9
Luni 9
Abuja 8
Norwalk 8
Phoenix 8
Abidjan 7
San Francisco 7
Bologna 6
Chennai 6
Dong Ket 6
Redondo Beach 6
Andover 5
Bari 5
Bengaluru 5
Charlotte 5
Livorno 5
New Delhi 5
Orem 5
Ottawa 5
Padua 5
Queens 5
Turin 5
Washington 5
Amman 4
Amsterdam 4
Atlanta 4
Catania 4
Clifton 4
Falls Church 4
Genoa 4
Haiphong 4
Hải Dương 4
Ioannina 4
Johannesburg 4
Montreal 4
Naples 4
Ninh Bình 4
Salerno 4
Salvador 4
Ankara 3
Baghdad 3
Barcelona 3
Buenos Aires 3
Totale 4.300
Nome #
A novel allergen-adjuvant conjugate suitable for specific immunotherapy of respiratory allergy 384
Treatment with 8-OH-modified adenine (TLR7 ligand)-allergen conjugates decreases T helper type 2-oriented murine airway inflammation 363
Dermatophagoides pteronyssinus group 2 allergen bound to 8-OH modified adenine reduces the Th2-mediated airway inflammation without inducing a Th17 response and autoimmunity 301
Efficacy and safety of mepolizumab (Anti-Interleukin-5) treatment in Gleich's syndrome 235
High proportion of inflammatory CD62Llow eosinophils in blood and nasal polyps of severe asthma patients 226
The TLR7 Ligand 9-Benzyl-2-Butoxy-8-Hydroxy Adenine Inhibits IL-17 Response by Eliciting IL-10 and IL-10-Inducing Cytokines. 206
Skin testing and infliximab-specific antibodies detection as a combined strategy for preventing infusion reaction. 205
The percentage of patients achieving complete remission of urticaria increases with repeated courses of treatment 204
Assays and strategies for immunogenicity assessment of biological agents. 200
Drug-Specific Th2 Cells and IgE Antibodies in a Patient with Anaphylaxis to Rituximab 188
A novel nDer p2-conjugated TLR7 down-modulates Th2-associated lung inflammation by using a therapeutical protocol 185
Anti-infliximab IgE and non-IgE antibodies and induction of infusion-related severe anaphylactic reactions. 181
The anti-IgE monoclonal antibody omalizumab as adjuvant treatment in desensitization to carboplatin in patients with ovarian cancer 176
Manifestations of Antidrug Antibodies Response: Hypersensitivity and Infusion Reactions. 170
Low-dose mepolizumab effectiveness in patients suffering from eosinophilic granulomatosis with polyangiitis 167
Prompt Predicting of Early Clinical Deterioration of Moderate-to-Severe COVID-19 Patients: Usefulness of a Combined Score Using IL-6 in a Preliminary Study 167
A modified adenine chemically coupled to allergen molecole redirects allergen-specific Th2 cells 159
Long-term retention rate of mepolizumab treatment in severe asthma: a 36-months real-life experience 157
A novel antigen-conjugated TLR7 ligand regulates the lung inflammation and Th2-mediated response in a murine model of asthma 157
Modified adenine (9-benzyl-2-butoxy-8-hydroxyadenine) redirects Th2-mediated murine lung inflammation by triggering TLR7. 157
Etanercept inhibits the TNF-α driven shifting of Th17 towards non-classic Th1 phenotype in juvenile idiopathic arthritis. 150
Comparison of ELISA with automated ECLIA for IL-6 determination in COVID-19 patients: An Italian real-life experience 148
Drug-specific Treg cells are induced during desensitization procedure for rituximab and tocilizumab in patients with anaphylaxis 142
Modified adenine (9-benzyl-2-butoxy-8-hydroxyadenine) redirects Th2-mediated murine lung inflammation by triggering TLR7. 142
Allergological in vitro and in vivo evaluation of patients with hypersensitivity reactions to infliximab. 139
Hydroxy-adenines as in vivo and in vitro immunomodulators of allergic responses 138
Circulating T cells to infliximab are detectable mainly in treated patients developing anti-drug antibodies and hypersensitivity reactions 135
Post-translational modifications of fibrinogen: implications for clotting, fibrin structure and degradation 134
The Kinetics of Antidrug Antibodies, Drug Levels, and Clinical Outcomes in Infliximab-Exposed Patients with Immune-Mediated Disorders 131
Short and long-term effect of a novel nDer p2-conjugated TLR7 ligand in the prevention of allergic lung inflammation 129
Fibrinogen Structural Changes and Their Potential Role in Endometriosis-Related Thrombosis 127
Immunogenicity of Biological Agents: Basic Knowledge and Clinical Implications 116
Dietary Antioxidants and Natural Compounds in Preventing Thrombosis and Cardiovascular Disease 104
Modified (2-Butoxy-8-Hydroxy-9-Benzyl) adenine redirects type 2 murine lung inflammation by triggering TLR7 in dendritic cells 101
The Erythrocyte–ROS Axis in Thrombosis and Hemostasis 82
Fibrinogen Oxidation and Thrombosis: Shaping Structure and Function 79
Fibrinogen glycosylation and glycation: molecular insights into thrombosis and vascular disease 77
Homocysteinylation of Fibrinogen: A Post-Translational Link to Thrombosis 70
ROS‐induced modifications of fibrin clots connect immune responses to atherothrombosis in systemic lupus erythematosus 59
Complete blood count in neonatal Intensive care Unit (NICU): Performance comparison between POCT Sight OLO® and Sysmex XN-9100™ hematology analyzers 47
Reactive Nitrogen Species and Fibrinogen: Exploring the Effects of Nitration on Blood Clots 41
Reactive Oxygen Species–Induced Modifications of Fibrin Clots as a Link Between Immune Responses and Atherothrombosis in Systemic Lupus Erythematosus 15
null 14
Totale 6.508
Categoria #
all - tutte 18.738
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.738


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022196 0 16 16 5 8 11 7 19 7 11 45 51
2022/2023589 48 124 29 34 40 95 73 36 81 5 13 11
2023/2024291 15 23 32 24 34 38 21 58 6 11 10 19
2024/20251.624 64 169 102 262 416 181 40 82 92 56 81 79
2025/20262.464 252 269 227 183 265 95 303 119 158 154 146 293
2026/202794 94 0 0 0 0 0 0 0 0 0 0 0
Totale 6.508